Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 2 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Legend Biotech Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 206 | 2 | 192 | −12 |
| Shares | 85.8M | 9.14K | 86.5M | +688.7K (+0.8%) |
| Value | $5.16B | $550.6K | $4.85B | −$311.1M (−6.0%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (26)
Institutions that held Legend Biotech Corp at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (38)
Institutions that held Legend Biotech Corp at the end of Q4 2023 and filed for Q1 2024 without it.
Not filed for Q1 2024 yet (2)
Institutions that held Legend Biotech Corp at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| AtonRa Partners | 8,847 | $532.3K |
| Coppell Advisory Solutions LLC | 297 | $18.3K |